Alcohol (ethanol) use is a global, health-related problem that spans a continuum ranging from low-risk, at-risk, and problem drinking to alcohol dependence and chronic abuse. Clinicians and researchers alike have the need to quantify drinking patterns to determine the risk for adverse, health-related events such as injury, liver damage, and cancer. Biochemical measures of ethanol consumption are affected by temporal patterns of drinking as well as individual characteristics such as gender and age. The choice of a laboratory analysis to determine ethanol consumption is complex; no single laboratory test will predict drinking accurately across all drinking patterns, across the life span, and across gender. In conjunction with interviews and physical assessment, however, biochemical laboratory tests are sensitive tools used to measure both recent and long-term patterns of alcohol consumption.
Get full access to this article
View all access options for this article.
References
1.
Allen JP, Litten RZ, Fertig JB, Babor T. 1997. Areviewof research on the Alcohol Use Disorders Identification Test (AUDIT). Alcohol Clin Exp Res21:613-9.
2.
Allen JP, Sillanaukee P, Anton J. 1999. Contribution of carbohydrate deficient transferrin to gamma glutamyl transpeptidase in evaluating progress of patients in treatment for alcoholism. Alcohol Clin Exp Res23:115-20.
3.
Anton RF, Dominick C, Bigelow M, Westby C. 2001. Comparison of Bio-Rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with gamma-glutamyl transferase. Clin Chem47:1769-75.
4.
Anton RF, Stout RL, Roberts JS, Allen JP. 1998. The effect of drinking intensity and frequency on serum carbohydrate-deficient transferrin and γ-glutamyl transferase levels in outpatient alcoholics. Alcohol Clin Exp Res22:1456-62.
5.
Barry KL, Fleming MF. 1993. The Alcohol Use Disorders Identification Test (AUDIT) and the SMAST-13: predictive validity in a rural primary care sample. Alcohol Alcohol28:33-42.
6.
Bates ME, Martin C. 1997. Immediate, quantitative estimation of blood alcohol concentration from saliva. J Stud Alcohol58:531-8.
7.
Bearer CF, Lee S, Salvator AE, Swick A, Yamashita T, Singer L. 1999. Ethyl linoleate in meconium: a biological marker for prenatal ethanol exposure. Alcohol Clin Exp Res23:487-93.
8.
Bearer CF, Salvator AE, Lee S, Buck K, Swick A, Haxhiu R, Washah S, Singer LT. 2000. FAEE in meconium predicts outcome. Alcohol Clin Exp ResS24:102A.
9.
Bendtsen P, Jones AW, Helander A. 1998. Urinary excretion of methanol and 5-hydroxytryptophol as biochemical markers of recent drinking in the hangover state. Alcohol Alcohol33:431-8.
Bradley KA, Boyd-Wickizer J, Powell SH, Burman ML. 1998. Alcohol screening questionnaires in women: a critical review. JAMA280:166-71.
12.
Cherpitel CJ. 1995. Screening for alcohol problems in the emergency room: a rapid alcohol problems screen. Drug Alcohol Depend40:133-7.
13.
Cherpitel CJ. 1997. Brief screening instruments for alcoholism. Alcohol Health Res World21:348-51.
14.
Cherpitel CJ. 1999. Screening for alcohol problems in the U.S. general population: a comparison of the CAGE and TWEAK by gender, ethnicity, and services utilization. J Stud Alcohol60:705-11.
15.
Cherpitel CJ. 2000. A brief screening instrument for problem drinking in the emergency room: the RAPS4 rapid alcohol problems screen. J Stud Alcohol61:447-9.
16.
Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B. 2002. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaboration project. Alcohol Clin Exp Clin Res26:332-9.
17.
Davies BT, Bowen CK. 1999. Total body water and peak alcohol concentration: a comparative study of young, middle-age, and older females. Alcohol Clin Exp Res23:969-75.
18.
Dufour DR, Lott JA, Henry JB. 2001. Clinical enzymology. In: Henry JB, editor. Clinical diagnosis and management by laboratory methods. 20th ed. Philadelphia: WB Saunders. p 281-303.
19.
Dufour MC. 1999. What is moderate drinking? defining “drinks” and drinking levels. Alcohol Res Health23:5-14.
20.
Ewing JA. 1984. Detecting alcoholism: the CAGE questionnaire. JAMA252:1905-7.
21.
Figlie NB, Benedito-Silva MGM, Souza-Formigoni MLO. 2002. Biological markers of alcohol consumption in nondrinkers, drinkers, and alcohol-dependent Brazilian patients. Alcohol Clin Exp Res26:1062-9.
22.
Fleming M, Mihic SJ, Harris RA. 2001. Ethanol. In: Hardman JG, Limbird LE, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill. p 429-45.
23.
Frezza M, DiPadova C, Pozzato G, Terpin M, Baraona E, Lieber CS. 1990. High blood alcohol levels in women: the role of decreased gastric alcohol dehydrogenase activity in first-pass metabolism. N Engl J Med322:95-9.
24.
Gibb K, Yee A, Johnson C, Martin S, Nowak R. 1984. Accuracy and usefulness of a breath alcohol analyzer. Ann Emerg Med13:516-20.
25.
Harasymiw JW, Bean P. 2001. Identification of heavy drinkers by using the early detection of alcohol consumption score. Alcohol Clin Exp Res25:228-35.
26.
Harrell AV, Wirtz PW. 1985. The Adolescent Drinking Index professional manual. Odessa (FL): Psychological Assessment Resources.
27.
Harrell AV, Wirtz PW. 1989. Screening for adolescent problem drinking: Validation of a multidimensional instrument for case identification. J Consult Clin Psychol1:61-3.
28.
Helander A, Eriksson JP. 2002. Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA study on state and trait markers of alcohol use and dependence. Alcohol Clin Exp Res26:1070-7.
29.
Henry JB. 2001. Clinical diagnosis and management by laboratory methods. 20th ed. Philadelphia: WB Saunders.
30.
Hermansson U, Helander A, Huss A, Brandt L, Ronnberg S. 2000. The alcohol use disorders identification test (AUDIT) and carbohydrate-deficient transferrin (CDT) in a routine workplace examination. Alcohol Clin Exp Res24:180-7.
31.
Iffland R. 1996. New ways to use biochemical indicators of alcohol abuse to regrant licences in a fairer manner after drunken driving in Germany. Alcohol Alcohol31:619-20.
32.
International Center for Alcohol Policies. 2002. Blood alcohol concentration limits worldwide. ICAP Reports 11. Retrieved May 2002 from http://www.icap.org/pdf/report11.pdf
33.
Intoximeters Incorporated. 2002. Alco-Sensor. Retrieved 1 September 2002 from http://www.intoximeters.com
Jones AW, Helander A. 1999. Time course and reproducibility of urinary excretion profiles of ethanol, methanol, and the ratio of serotonin metabolites after intravenous infusion of ethanol. Alcohol Clin Exp Res23:1921-6.
36.
Kaplan A, Jack R, Opheim K, Toivola B, Lyon A. 1995. Clinical chemistry: interpretation and techniques. 4th ed. Baltimore (MD): Williams & Wilkins.
37.
Kitchens JM. 1994. Does this patient have an alcohol problem? JAMA272:1782-7.
38.
Klein J, Debowski J, Paciorek C, Chan D, Koren G. 2000. Fatty acid ethyl esters—a novel biological marker for heavy in utero ethanol exposure: in vitro studies. Alcohol Clin Exp ResS24:102A.
39.
Leusink G, Smeets-Goevaers CG, Breed SA, Keyzer JJ, van Pelt J. 2000. Carbohydrate-deficient transferrin in relation to the menopausal status of women. Alcohol Clin Exp Res24:172-5.
40.
Little BB, Snell LM, Rosenfeld CR, Gilstrap LC, Gant NF. 1990. Failure to recognize fetal alcohol syndrome in newborn infants. Am J Dis Child144:1142-6.
41.
Lucey MR, Hill EM, Young JP, Demo-Dananberg L, Beresford TP. 1999. The influence of age and gender on blood ethanol concentrations in healthy humans. J Stud Alcohol60:103-10.
42.
Manwell LB, Fleming MF, Johnson K, Barry K. 1998. Tobacco, alcohol, and drug use in a primary care sample: 90-day prevalence and associated factors. J Addict Dis17:67-81.
43.
McClatchey K. 1994. Clinical laboratory medicine. Baltimore: Williams & Wilkins.
44.
Meerkerk GJ, Njoo KH, Bongers IMB, Trienekens P, van Oers JA. 1999. Comparing the diagnostic accuracy of carbohydrate deficient tranferrin, glutamyltransferase, and mean cell volume in a general practice population. Alcohol Clin Exp Res23:1052-9.
45.
Menninger JA, Baron AE, Conigrave KM, Whitfield JB, Saunders JB, Helander A, Eriksson CJ, Grant B, Hoffman PL, Tabakoff B. 2000. Platelet adenylyl cyclase activity as a trait marker of alcohol dependence. Alcohol Clin Exp Res24:810-21.
46.
National Institute on Alcohol Abuse and Alcoholism. 2000. Tenth special report on alcohol and health. Bethesda (MD): NIAAA.
47.
National Institute on Alcohol Abuse and Alcoholism. 2002. Quick facts, NIAAA data bases: percent who drink beverage alcohol, by gender, 1939-2000. Retrieved 1 September 2002 from http://www.niaaa.nih.gov/databases/dkpat1.txt
48.
Oslin DW, Pettinati HM, Luck G, Semwanga A, Cnaan A, O’Brien CP. 1998. Clinical correlations with carbohydrate deficient transferrin levels in women with alcoholism. Alcohol Clin Exp Res22:1981-5.
49.
Pincus, MR, Abraham, NZ. 2001.Toxicology and therapeutic drug monitoring. In: Henry JB, editor. Clinical diagnosis and management by laboratory methods. 20th ed. Philadelphia: WB Saunders. p 359-60.
50.
Pokorny AD, Miller BA, Kaplan HB. 1972. The brief MAST: a shortened version of the Michigan Alcoholism Screening Test. Am J Psychiatry129:342-5.
51.
Ponnio M, Alho H, Heinala P, Nikkari ST, Sillanaukee P. 1999. Serum and saliva levels of sialic acid are elevated in alcoholics. Alcohol Clin Exp Res23:1060-4.
52.
Quanta Heathcare Solutions. 2002. Evaluation of patients for alcohol use and abuse. Medical Algorithms Project, version 9.6, July 2002. Retrieved 1 September 2002 from http://216.157.50.80/docs_ch32/doc_ch32.14.html#A32.14.04
53.
Ravel R. 1997. Clinical laboratory medicine: clinical application of laboratory data. 6th ed. St. Louis (MO): Mosby.
54.
Reinert DF, Allen JP. 2002. The alcohol use disorders identification test (AUDIT): a review of recent research. Alcohol Clin Exp Res26:272-9.
55.
Room R. 1990. Measuring alcohol consumption in the United States: methods and rationale. In: Kozlowski LT, Annis HM, Cappell HD, Glaser FB, Goodstadt MS, Israel Y, Kalant H, Sellers EM, Vingilis EF, editors. Research advances in alcohol and drug problems. Vol 10. New York: Plenum. p 39-80.
56.
Rukstalis MR, Lynch KG, Oslin DW, Pettinati HM, Anderson SM, Volpicelli JR, Anton RF. 2002. Carbohydrate-deficient transferrin levels reflect heavy drinking in alcohol-dependent women seeking treatment. Alcohol Clin Exp Res26:1537-44.
57.
Russell M, Martier SS, Sokol, RJ, Jacobson S, Jacobson J, Bottoms, S. 1991. Screening for pregnancy risk-drinking: TWEAKing the tests. Alcohol Clin Exp Re15:368.
58.
Russell M, Martier SS, Sokol RJ, Mudar P, Bottoms S, Jacobson S, Jacobson J. 1994. Screening for pregnancy risk-drinking. Alcohol Clin Exp Res18:1156-61.
59.
Russell M, Martier SS, Sokol, RJ, Mudar P, Jacobson S, Jacobson J. 1996. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health86:1435-9.
60.
Sacher RA, McPherson RA. 1991.Widmann’s clinical interpretation of laboratory tests. Philadelphia: F. A. Davis.
61.
Saunders JB, Aasland OG, Babor TF, De La Fuenta JR, Grant M. 1993. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption—Part II. Addiction88:791-804.
62.
Saunders JB, Lee NK. 2000. Hazardous alcohol use: its delineation as a subthreshold disorder, and approaches to its diagnosis and management. Compr Psychiatry2:95-103.
63.
Schuckit MA. 2001. Alcohol and alcoholism. In: Brunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s principles of internal medicine. 15th ed. New York: McGraw-Hill.
64.
Selzer ML. 1971. The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am J Psychiatry127:1653-8.
65.
Selzer ML, Vinokur A, van Rooijen LA. 1975. A self-administered Short Michigan Alcoholism Screening Test (SMAST). J Stud Alcohol36:117-26.
66.
Sillanaukee P, Ponnio M, Seppa K. 1999. Sialic acid: new potential marker of alcohol abuse. Alcohol Clin Exp Res23:1039-43.
67.
Sillanaukee P, Strid N, Allen JP, Litten RZ. 2001. Possible reasons why heavy drinking increases carbohydrate-deficient transferrin. Alcohol Clin Exp Res25:34-40.
68.
Soderstrom CA, Smith GS, Kufera JA, Dischinger PC, Hebel JR, McDuff DR, Gorelick DA, Ho SM, Kerns TJ, Read KM. 1997. The accuracy of the CAGE, the Brief Michigan Alcoholism Screening Test, and the Alcohol Use Disorders Identification Test in screening trauma center patients for alcoholism. J Trauma43:962-9.
69.
Sokol RJ, Martier SS, Ager JW. 1989. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol160:863-70.
70.
Stibler H. 1991. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful ethanol consumption review. Clin Chem37:2029-37.
71.
Stoler JM, Huntington KS, Peterson CM, Peterson KP, Daniel P, Aboagye KK, Leiberman E, Ryan L, Holmes LB. 1998. The prenatal detection of significant alcohol exposure with maternal blood markers. J Pediatr133:346-52.
72.
Storgaard H, Nielsen SD, Gluud C. 1994. The validity of the Michigan Alcoholism Screening Test (MAST). Alcohol Alcohol29:493-502.
73.
van Pelt J, Leusink GL, van Nierop PWM, Keyzer JJ. 2000. Test characteristics of carbohydrate-deficient transferrin and γ glutamyltransferase in alcohol-using perimenopausal women. Alcohol Clin Exp Res24:176-9.
74.
Venes D. 2001. Taber’s cyclopedic medical dictionary. 19th ed. Philadelphia: FA Davis.
75.
Walitzer KS, Connors GJ. 1999. Treating problem drinking. Alcohol Res Health23:138-43.
76.
Wallach, J. 2000. Interpretation of diagnostic tests. 7th ed. Philadelphia: Lippincott Williams & Wilkins.
77.
Wong CK, Lam CWK. 2002. Carbohydrate-deficient transferrin: a marker of alcohol abuse. Hong Kong Society of Clinical Chemistry5:23-6.
78.
World Health Organization. 2002. Substance abuse: the mission. 2000. Retrieved 1 September 2002 from http://www.who.int/substance_abuse/pages/about.html
79.
Yersin B, Nicolet J, Dercrey H, Burnier M, van Melle G, Pecoud A. 1995. Screening for excessive alcohol drinking: comparative value of carbohydrate deficient transferrin, gamma glutamyl transferase, and mean corpuscular volume. Arch Intern Med155:1907-11.
